Europe automated breast ultrasound systems market growth is spurred by the rising awareness about breast cancer screening coupled with growing number of initiatives. Breast cancer screening program (BCSP) was extensively implemented for early breast cancer screening in Russia. The program offers screening at 2-year intervals to women between 40 to 60 years of age. Such initiatives are estimated to impel the adoption of ABUS in recent years.
Europe Automated Breast Ultrasound Systems (ABUS) Market is estimated to reach USD 328 Million by 2024. Restricted capability of mammography systems to diagnose breast cancer in
dense breast tissues will positively impact ABUS business growth. ABUS assists
in detecting small tumors at early stage of breast cancer that can
significantly reduce treatment cost due to early diagnosis. Various studies
have proved superlative detection rate of ABUS over mammography system. Thus,
superior screening and detection rate over mammography system will drive demand
for automated imaging modalities in foreseeable years.
Automated breast ultrasound system segment held significant market size of
USD 51.1 million in 2017. Higher detection rate of breast cancer than
mammography systems increases the customer preference for ABUS. In addition,
enhanced or large field of view of breast and decreased time for generating
breast images contribute to the benefits, that will result into segmental
expansion over the coming years.
Diagnostic imaging centers segment will grow at rapid pace of 13.0% CAGR.
Growing healthcare spending on cancer treatment for patients in Europe will
offer attractive opportunity for segmental expansion. Implementation of
national screening program in the region will further stimulate segmental share
in foreseeable years.
Few of the established market players in Europe automated breast ultrasound
systems market are GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V.,
Siemens AG, SonoCine Inc., and Theraclion. Industry players are concentrating
efforts on strategic alliances such as agreements, mergers and acquisitions for
fortifying market presence and for capturing profits. For instance, in July
2016, Royal Philips strategically partnered with Andalusian Health Service,
Spain. Partnership with various hospitals ensures installation, integration,
maintenance, and updates of medical technologies provided by the firm in order
to achieve optimal delivery of care.
